New targets for mucosal healing and therapy in inflammatory bowel diseases.
about
Structural and molecular features of intestinal strictures in rats with Crohn's-like diseaseRole of regulatory T cell in the pathogenesis of inflammatory bowel diseaseWound repair: role of immune-epithelial interactionsContribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel diseaseSizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.Ultrasound-mediated gastrointestinal drug delivery.Regulation of tumour necrosis factor signalling: live or let dieValidation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug EffectsStructural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel diseaseDetection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasoundDifferential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.A gp130-Src-YAP module links inflammation to epithelial regeneration.Antisense approach to inflammatory bowel disease: prospects and challenges.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease.Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in miceBifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.Immunopathogenesis of IBD: current state of the art.Reparative inflammation takes charge of tissue regeneration.The microbial pharmacists within us: a metagenomic view of xenobiotic metabolismA Microbial Feed Additive Abates Intestinal Inflammation in Atlantic SalmonThe matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6.Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionOral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in miceCorticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.Inflammatory bowel disease-related arthritis - clinical evaluation and possible role of cytokines.Interleukin-17 and type 17 helper T cells in cancer management and research.JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokinesAnimal models of ulcerative colitis and their application in drug research.Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.Making sense of the cause of Crohn's - a new look at an old disease.The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseTargeting integrins and adhesion molecules to combat inflammatory bowel disease.Applying nanomedicine in maladaptive inflammation and angiogenesis.Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders.Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease.G-protein-coupled receptor kinase-2 is a critical regulator of TNFα signaling in colon epithelial cells.MKL1 is an epigenetic mediator of TNF-α-induced proinflammatory transcription in macrophages by interacting with ASH2.Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.
P2860
Q24658466-46585779-02E4-4D54-A7A4-5FF7D1638620Q26768560-FB2D578C-DB5A-42A5-B1AF-4B5766B36B64Q26801818-BE6640FA-FB83-4F53-8BFF-64FED72A0302Q27027429-55E102E6-D4FC-4EB4-9C24-52D24456F009Q27324846-70C4FCDA-7DEC-4FC6-B142-FB02E39D023BQ27325548-12B866AF-342E-4A3A-95B2-736A85DD26B9Q28262381-F5434F2C-1CE6-4FAB-9F00-CFD896827891Q28552013-C40D15BB-B57C-4F84-9343-AE7E91969C74Q28821002-2DC02E90-6D6C-4883-AFDF-1B9F23416E26Q30356090-F02AD77F-C219-47DB-86D2-32F344171363Q30815146-523A355A-4771-4784-B8F2-487019A95B05Q34465259-69B1BE4C-BCDE-4E81-9753-B1BE4DDC62EDQ34473572-236419D3-3084-4221-9E04-EA942454B7C2Q34786166-A1C4E026-FDFE-42C3-BFEE-6666BF9A6239Q35182119-DC9FC481-8C6F-46CC-AF86-1D41F977FA72Q35563351-1D91EA8A-E45C-46BF-8BDA-90A3377DD278Q35719834-140273CA-43AA-4212-8596-F11EBFB1EA80Q35857951-9BBAF496-275C-4D59-AAB8-B6F7C32F13E2Q35899475-FFC1566F-7309-437E-9260-08C15902C3C8Q35955534-534FA731-EC82-4A87-B4BF-2894FCCE4A4EQ35969999-BCE88482-4318-457B-9F45-6D10B7AAB7E8Q36093753-B989E408-529E-44F4-ABAF-45512A38F630Q36114510-5763A30D-50B5-4A45-A236-FEE5DE577499Q36317250-57B390A9-40DE-4BFF-A895-48EBE1DB5B92Q36465772-EBA45D80-8F75-4C14-9794-1399D39AC55CQ36842484-482EEC70-4206-4C52-A941-CE4195803EA7Q37031654-DF31347F-6D52-4B64-AD78-4F90AB6C6C7BQ37148745-BD139AFA-EDAA-43D3-82FE-7F5C8A19111FQ37312835-1DC8FA06-3AE7-4ACC-AF5D-2A60E84EEC24Q37413157-CCFBF934-D35E-4EDD-8887-BC2558C250D0Q37577712-2A8812BC-4364-4139-8712-652334DEF4E6Q38176299-52CDFA4D-1E78-4AB2-A1DC-7D87F085AF18Q38248635-C99B6D31-C9B0-447E-8EE2-019AF200067BQ38557650-42AA3C38-5E6B-4AD1-9B5C-9AA5D954E082Q38665573-28C0C3D9-E760-4AFE-8A3D-17FE42271ACBQ38671272-0A0BB56A-37AF-4A96-ADC2-91F200BD9927Q38701571-A17DB963-6481-4487-AD6C-4EAA15D089ABQ38715627-11B477D3-8F7D-4CE0-AA21-178C4C7781F0Q38744710-AA4C33CC-530D-44AE-AA68-EA1088D7232BQ38750548-690631C9-92D5-4871-AEDA-82585ADD555C
P2860
New targets for mucosal healing and therapy in inflammatory bowel diseases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@ast
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@en
type
label
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@ast
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@en
prefLabel
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@ast
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@en
P356
P1433
P1476
New targets for mucosal healing and therapy in inflammatory bowel diseases.
@en
P2093
M F Neurath
P2888
P356
10.1038/MI.2013.73
P577
2013-10-02T00:00:00Z